Macerich Company (The) Common Stock vs Oruka Therapeutics Inc. Common Stock — how do they compare? Macerich Company (The) Common Stock trades at $22.18 (market cap $6.39B), while Oruka Therapeutics Inc. Common Stock trades at $75.2 (market cap $5.18B). The key difference: Macerich Company (The) Common Stock is the larger of the two by market cap, and Macerich Company (The) Common Stock pays a 3.02% dividend while Oruka Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Macerich Company (The) Common Stock for 0 Days and Oruka Therapeutics Inc. Common Stock for 0 Days on average.
| MAC | ORKA | |
|---|---|---|
Market Cap | $6.39B | $5.18B |
Volume | 2,684,151 | 490,798 |
Sector | Real Estate | Health |
52-Week High | $26.51 | $113.08 |
52-Week Low | $16.20 | $26.19 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $11.07B | $4.31B |
Dividend Yield | 3.02% | — |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
The Macerich Company is a real estate investment trust that owns, operates, and redevelops shopping centers concentrated in California, the Pacific Northwest, and other major US markets.
Read more on MAC →Oruka Therapeutics, Inc. is a clinical-stage biotechnology company developing extended half-life monoclonal antibodies for plaque psoriasis, psoriatic arthritis, and related dermatologic conditions, with lead candidates ORKA-001 and ORKA-002 in clinical trials.
Read more on ORKA →